Aberrant promoter methylation and tumor suppressive activity of the DFNA5 gene in colorectal carcinoma
- 28 January 2008
- journal article
- Published by Springer Science and Business Media LLC in Oncogene
- Vol. 27 (25), 3624-3634
- https://doi.org/10.1038/sj.onc.1211021
Abstract
To identify novel methylated gene promoters, we compared differential RNA expression profiles of colorectal cancer (CRC) cell lines with or without treatment of 5-aza-2′-deoxycytidine (5-aza-dC). Out of 1776 genes that were initially ‘absent (that is, silenced)’ by gene expression array analysis, we selected 163 genes that were increased after 5-aza-dC treatment in at least two of three CRC cell lines. The microarray results were confirmed by Reverse Transcription–PCR, and CpG island of the gene promoters were amplified and sequenced for examination of cancer-specific methylation. Among the genes identified, the deafness, autosomal dominant 5 gene, DFNA5, promoter was found to be methylated in primary tumor tissues with high frequency (65%, 65/100). Quantitative methylation-specific PCR of DFNA5 clearly discriminated primary CRC tissues from normal colon tissues (3%, 3/100). The mRNA expression of DFNA5 in four of five colon cancer tissues was significantly downregulated as compared to normal tissues. Moreover, forced expression of full-length DFNA5 in CRC cell lines markedly decreased the cell growth and colony-forming ability whereas knockdown of DFNA5 increased cell growth in culture. Our data implicate DFNA5 as a novel tumor suppressor gene in CRC and a valuable molecular marker for human cancer.Keywords
This publication has 20 references indexed in Scilit:
- Identification of DFNA5 as a target of epigenetic inactivation in gastric cancerCancer Science, 2006
- The potential role of DFNA5, a hearing impairment gene, in p53-mediated cellular response to DNA damageJournal of Human Genetics, 2006
- DNA methylation of genes linked with retinoid signaling in gastric carcinomaCancer, 2005
- CpG island methylation in aberrant crypt foci and cancers from the same patientsInternational Journal of Cancer, 2005
- Cancer Statistics, 2005CA: A Cancer Journal for Clinicians, 2005
- Silencing of the IGF1R gene enhances sensitivity to DNA-damaging agents in both PTEN wild-type and mutant human prostate cancerCancer Gene Therapy, 2004
- Aberrant cellular retinol binding protein 1 (CRBP1) gene expression and promoter methylation in prostate cancerJournal of Clinical Pathology, 2004
- A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancerNature Genetics, 2002
- Hypermethylation of tumor suppressor genes in cancerSeminars in Cancer Biology, 1999
- Hypomethylation of DNA from Benign and Malignant Human Colon NeoplasmsScience, 1985